Eva Haegler‐Laube
Kantonsspital Baden(CH)
Publications by Year
Research Areas
Childhood Cancer Survivors' Quality of Life, Chemotherapy-induced cardiotoxicity and mitigation, Cancer survivorship and care, Venous Thromboembolism Diagnosis and Management, Cancer-related cognitive impairment studies
Most-Cited Works
- → Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)(2020)351 cited
- → Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology(2020)328 cited
- → Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry(2022)38 cited
- → Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience(2019)32 cited
- → Diagnosing Preclinical Cardiac Dysfunction in Swiss Childhood Cancer Survivors: Protocol for a Single-Center Cohort Study(2020)9 cited
- → Prevalence and factors associated with cancer-related fatigue in Swiss adult survivors of childhood cancer(2023)6 cited
- → Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease(2018)3 cited
- → Recommendations for cancer related fatigue in post-treatment survivorship care: a cross-sectional analysis of guidelines(2026)1 cited
- → Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk(2018)1 cited
- → Prospective Single Center Cohort Study for Early Diagnosis of Cardiac Dysfunction in Swiss Childhood Cancer Survivors: A Study Protocol(2020)